Join Marc Ussini and Ned Mumtaz, from Vector Health as they have an in depth discussion on Lessons Learned, Challenges Overcome and Adaptations Made in 2020 to Ensure Continuity with Michelle Kock of Exact Sciences and Karen Snyder of MorphoSys.
1 – Summarize OIG Fraud Alert and identify 8 specific checks that organizations should perform regularly against the speaker program activity
2 – Managing Organization’s Compliance culture
3 – An Insight to Virtual Events, including Speaker Programs and delivering Virtual Meals
4 – Innovation and Creativity in Compliance
Ned Mumtaz has over 25 years of experience in the pharmaceutical industry. He has worked as Director for Wyeth Pharmaceuticals, Schering Plough, Eisai, and Otsuka. Additionally, he has also been a consultant and an advisor for over 50 drug, biologics and device manufacturers.
Karen Snyder has over 7 years of experience in US and Global pharmaceutical compliance in a variety of companies including Takeda, Morphosys, Surgical Specialties Corporation & Vertex Pharmaceuticals. She currently holds the position of Associate Director, Compliance at MorphoSys.
Marc has over two decades of BioPharma experience.He oversees the delivery of Vector Health’s compliance products and services. He has led the implementation of various projects impacting spend transparency for both large and small manufacturers.
Michelle Kock has over 17 years of experience in pharmaceutical compliance, having previously served senior roles in GE Healthcare and Zimmer Biomet. She currently holds the position of senior Senior Director of Compliance at Exact Sciences.